KR100696422B1 - 항생물질로서 사이클릭 아미노구아니딘 치환체를 가진세팔로스포린 - Google Patents

항생물질로서 사이클릭 아미노구아니딘 치환체를 가진세팔로스포린 Download PDF

Info

Publication number
KR100696422B1
KR100696422B1 KR1020007010434A KR20007010434A KR100696422B1 KR 100696422 B1 KR100696422 B1 KR 100696422B1 KR 1020007010434 A KR1020007010434 A KR 1020007010434A KR 20007010434 A KR20007010434 A KR 20007010434A KR 100696422 B1 KR100696422 B1 KR 100696422B1
Authority
KR
South Korea
Prior art keywords
alkyl
formula
hydrogen
group
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020007010434A
Other languages
English (en)
Korean (ko)
Other versions
KR20010074666A (ko
Inventor
아쉐르게르트
하일마이어베르너
루데쉐르요하네스
힐데브란트요하네스
쉬란츠미카엘
비저요셉
Original Assignee
나브리바 테라퓨틱스 포르슝즈 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 나브리바 테라퓨틱스 포르슝즈 게엠베하 filed Critical 나브리바 테라퓨틱스 포르슝즈 게엠베하
Publication of KR20010074666A publication Critical patent/KR20010074666A/ko
Application granted granted Critical
Publication of KR100696422B1 publication Critical patent/KR100696422B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020007010434A 1998-03-23 1999-03-19 항생물질로서 사이클릭 아미노구아니딘 치환체를 가진세팔로스포린 Expired - Fee Related KR100696422B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0051598A AT406772B (de) 1998-03-23 1998-03-23 Antibakterielle 7-acylamino-3-iminomethyl- cephalosporine und verfahren zu deren herstellung
ATA515/98 1998-03-23

Publications (2)

Publication Number Publication Date
KR20010074666A KR20010074666A (ko) 2001-08-08
KR100696422B1 true KR100696422B1 (ko) 2007-03-20

Family

ID=3492649

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007010434A Expired - Fee Related KR100696422B1 (ko) 1998-03-23 1999-03-19 항생물질로서 사이클릭 아미노구아니딘 치환체를 가진세팔로스포린

Country Status (25)

Country Link
US (1) US6440957B1 (enExample)
EP (2) EP1930335A1 (enExample)
JP (1) JP2002507616A (enExample)
KR (1) KR100696422B1 (enExample)
CN (1) CN1188418C (enExample)
AR (1) AR015248A1 (enExample)
AT (1) AT406772B (enExample)
AU (1) AU749735B2 (enExample)
BR (1) BR9908960A (enExample)
CA (1) CA2324953C (enExample)
CO (1) CO5080739A1 (enExample)
HU (1) HUP0101603A3 (enExample)
ID (1) ID26567A (enExample)
IL (2) IL138477A0 (enExample)
MY (1) MY119841A (enExample)
NO (1) NO20004760L (enExample)
NZ (1) NZ506908A (enExample)
PE (1) PE20000360A1 (enExample)
PL (1) PL343094A1 (enExample)
RU (1) RU2245884C2 (enExample)
SK (1) SK14152000A3 (enExample)
TR (1) TR200002749T2 (enExample)
TW (1) TWI250983B (enExample)
WO (1) WO1999048896A1 (enExample)
ZA (1) ZA200004850B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6693095B2 (en) * 1997-04-01 2004-02-17 Biochemie Gesellschaft M.B.H. Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates
DE102007052891A1 (de) 2007-11-02 2009-05-07 Evonik Degussa Gmbh Verfahren zur Stabilisierung von olefinisch ungesättigten Monomeren
DE102013204950A1 (de) 2013-03-20 2014-09-25 Evonik Industries Ag Verfahren und Zusammensetzung zur Inhibierung der Polymerisation von Cyclopentadienverbindungen
ES2624415T3 (es) 2014-09-08 2017-07-14 Evonik Degussa Gmbh (Tio)acetales fenólicos como agentes inhibidores de la polimerización de monómeros olefínicamente insaturados
TWI669317B (zh) 2014-09-22 2019-08-21 德商贏創德固賽有限責任公司 反應性單體的改良製造方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996035692A1 (en) * 1995-05-11 1996-11-14 Biochemie Gesellschaft Mbh Antibacterial cephalosporins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE943408C (de) * 1953-03-31 1956-05-17 Bayer Ag Verfahren zur Darstellung von Bisguanylhydrazonen
FI851934A7 (fi) * 1984-05-30 1985-12-01 Ici Plc Kefalosporiinijohdannaisia.
GB8721568D0 (en) * 1987-09-14 1987-10-21 Fujisawa Pharmaceutical Co Cephem compounds
NZ337732A (en) * 1997-04-01 2001-09-28 Biochemie Gmbh Antibacterial substituted 7-acylamino -3-(methylhydrazono) methyl-cephalosporins and intermediates

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996035692A1 (en) * 1995-05-11 1996-11-14 Biochemie Gesellschaft Mbh Antibacterial cephalosporins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Justus Liebigs Annalen der Chemie, Vol. 651, 1962�

Also Published As

Publication number Publication date
EP1082326A1 (en) 2001-03-14
ZA200004850B (en) 2002-02-27
JP2002507616A (ja) 2002-03-12
ID26567A (id) 2001-01-18
WO1999048896A1 (en) 1999-09-30
AR015248A1 (es) 2001-04-18
TR200002749T2 (tr) 2000-12-21
PE20000360A1 (es) 2000-05-17
CO5080739A1 (es) 2001-09-25
SK14152000A3 (sk) 2001-05-10
CA2324953C (en) 2008-05-13
AU749735B2 (en) 2002-07-04
AT406772B (de) 2000-08-25
CN1294593A (zh) 2001-05-09
NO20004760L (no) 2000-11-21
KR20010074666A (ko) 2001-08-08
IL138477A (en) 2007-06-17
NZ506908A (en) 2003-04-29
RU2245884C2 (ru) 2005-02-10
CN1188418C (zh) 2005-02-09
PL343094A1 (en) 2001-07-30
MY119841A (en) 2005-07-29
ATA51598A (de) 2000-01-15
US6440957B1 (en) 2002-08-27
AU3518899A (en) 1999-10-18
HUP0101603A2 (hu) 2001-12-28
IL138477A0 (en) 2001-10-31
HUP0101603A3 (en) 2002-10-28
NO20004760D0 (no) 2000-09-22
TWI250983B (en) 2006-03-11
CA2324953A1 (en) 1999-09-30
EP1930335A1 (en) 2008-06-11
BR9908960A (pt) 2000-12-05

Similar Documents

Publication Publication Date Title
EP0304019A2 (en) Novel crystalline 7-(2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid (syn isomer)
DE3485860T2 (de) Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
RU2183212C2 (ru) Антибактериальные цефалоспорины, фармацевтическая композиция на их основе и способ лечения
DE60209341T2 (de) Cephem-verbindungen
DK155943B (da) Analogifremgangsmaade til fremstilling af 7-d-(-)-alfa-amino-alfa-(p-acetoxyphenyl)acetamidocephalosporansyrer
SI9200204A (en) Diastereomers of 1-(isopropoxycarbonyloxy)ethylester 3-cephem-4-carboxylic acid and process for their production
EP0264091B1 (en) 3-propenylcephem derivative, preparation thereof, chemical intermediates therein, pharmaceutical composition and use
US4263302A (en) Quinolinecarboxylic acid substituted penicillins and pharmaceutical compositions containing the same
KR100696422B1 (ko) 항생물질로서 사이클릭 아미노구아니딘 치환체를 가진세팔로스포린
IE69040B1 (en) Crystallized cephem-acid addition salts and a process for the preparation thereof
DE69132578T2 (de) Cephemderivate
HU185644B (en) Process for producing 7-beta-square bracket-alpha-syn-methoxy-imino-alpha-bracket-2-amino-thiazol-4-yl-bracket closed-acetamido-square bracket closed-3-bracket-1,2,3-thiazol-5-yl-thio-nethyl-aracket closed-3-cepheme-4-carboxylic acid derivatives
DE2739448A1 (de) 7-substituierte aminoacetamido- oxadethiacephalosporine, verfahren zu deren herstellung und deren verwendung bei der behandlung bakterieller erkrankungen
AU651588B2 (en) Novel cephalosporin compounds and processes for preparation thereof
JPH0516437B2 (enExample)
KR100481143B1 (ko) 항균성 치환 7-아실아미노-3-(메틸히드라조노)메틸-세팔로스포린 및 중간체
HU182498B (en) Process for producing 7-bracket-iminoacetamido-bracket closed-3-thiomethyl-ceph-3-eme-4-caraoxylic acid
US4283398A (en) Cephalosporins
US4201781A (en) Substituted 7[s-oxopyrido[2,3-d]pyrimidine carboxamido acetamido]cephalosporins
US4296112A (en) Cephalosporins
US20050043289A1 (en) Crystalline hydrochloride of 7-(((5-amino-1,2,4-thiadiazol-3-yl) (fluoromethoxyimino)acetyl)amino)-3-((imino-1-piperazinylmethyl)methylhydrazono)-methyl-3-cephem-4-carboxylic acid
SU1705291A1 (ru) Производные 3-аммониопропенилцефем-4-карбоксилата, обладающие антибактериальной активностью, производное 3-йодпропенилцефема в качестве промежуточного продукта дл синтеза производных 3-аммониопропенилцефем-4-карбоксилата, 2-(5-тритиламино-1,2,4-тиадиазол-3-ил)-(Z)-2-фторметоксииминоуксусна кислота в качестве промежуточного продукта дл синтеза п-метоксибензил-7- @ -[2-(5-тритиламино-1,2,4-тиадиазол-3-ил) (Z)-(2-фторметоксииминоацетамидо)3-(Е)-(3-йод-1-пропен-1-ил)]-3-цефемкарбоксилата
AT403284B (de) 3-methylimino-3-cephemderivate
EP0098615B1 (en) 1-oxadethiacephalosporin compound and antibacterial agent containing the same
KR20000057441A (ko) 신규한 세펨 유도체

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

St.27 status event code: A-3-3-V10-V11-apl-PJ0201

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PB0901 Examination by re-examination before a trial

St.27 status event code: A-6-3-E10-E12-rex-PB0901

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

St.27 status event code: A-3-4-F10-F13-rex-PB0701

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

N231 Notification of change of applicant
PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20100313

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20100313

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000